Murphy, T., Zou, J., Arruda, A., Wang, T. T., Zhao, Z., Zheng, Y., Gupta, V., Maze, D., McNamara, C., Minden, M. D., Schimmer, A., Sibai, H., Yee, K., Capo-Chichi, J.-M., Stockley, T., Schuh, A., Bratman, S. V. and Chan, S. M. (2024) “Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute myeloid leukemia”, Haematologica. Pavia, Italy, 109(2), pp. 671-675. doi: 10.3324/haematol.2023.283510.